Evidence check: Triglyceride senken in the context of menopause

Lowering triglycerides during menopause is clinically relevant because estrogen decline often raises triglycerides and LDL cholesterol. The provided context lacks specific studies or guidelines on this topic. General recommendations include a Mediterranean diet, omega-3 fatty acids (e.g., from fish or flaxseed), regular exercise, and weight management. MyBody-X offers metabolic, DNA, and nutrient tests that may indicate individual risk factors – for example, genetic variants in lipid metabolism (e.g., APOA5, LPL) or inflammatory markers. However, the evidence for directly reducing triglycerides through such tests is weak to moderate; they provide orientation rather than clinical diagnosis. Important: For significantly elevated levels or additional risk factors (e.g., diabetes), medical evaluation is necessary. Hormone replacement therapy can affect triglycerides – this should be discussed with a physician. Evidence grade: mixed/unclear, as the context does not provide specific supporting data.